397 POSTER A phase I dose escalation and pharmacokinetic study of the novel mitotic checkpoint inhibitor GSK923295A in patients with solid tumors
R.A. Fleming, K.D. Holen, T.L. Cyr, B.M. Johnson, J.L.S. Gauvin, J.J. Lager, B. Williams, D.B. Alberti, B.L. Weber, V. ChungVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72331-0
File:
PDF, 61 KB
english, 2008